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Abstract
Background: A surge in pro-inflammatory markers, Il-6 and TNF-α, has been associated with type 2 diabetes
mellitus (T2DM). However, there is no data on the dynamics of these markers in T2DM Ghanaian populations. The
aim of this study was to determine variations in the levels of IL-6 and TNF-α in T2DM patients. This study also
examined the associations of IL-6 and TNF-α with anthropometric measurement and the effect of co-morbidity
with hypertension using rural and urban dwellers in the Ashanti region, Ghana.
Methods: A nested case–control design using participants aged 25–70 years consisting of 77 T2DM± hypertension
patients and 112 controls were selected from a larger study on Research on Obesity and Diabetes among African
Migrants (RODAM). Anthropometric measurements, blood pressure and body fat percentage were measured. Fasting
blood samples were analyzed for glucose, IL-6 and TNF-α levels.
Results: The median level of IL-6 was significantly higher (p < 0.0001) among rural dwellers compared to urban dwellers.
Inversely, urban dwellers had significantly higher (p = 0.0424) median level of TNF-α compared to rural cases. No
significant differences were observed in IL-6 (p = 0.3571) and TNF-α (p = 0.2581) among T2DM patients compared with
T2DM± hypertension patients. A weak negative correlation was found between IL-6 and BMI in urban T2DM.
Discussion: The average level of IL-6 was higher in rural T2DM participants compared with those in urban
setting. However, higher levels of TNF-α was observed among the study participants with T2DM in urban settings
compared to those of rural. In this study, we observed that co-morbidity of hypertension had no significant effect on the
levels of IL-6 and TNF-α. We are of the opinion that higher physical activity levels among rural particpants and high
obesity levels in urabn participants explain the observation but needs more numbers to validate.
Conclusion: This study revealed that IL-6 levels were higher among rural dwellers than urban while TNF-α levels were
higher in urban dwellers than rural in patients with T2DM. There was no association of body fat percentage and body
mass index with IL-6 and TNF-α levels. Co-morbidity of hypertension with T2DM had no effect on IL-6 and TNF-α levels.
Background
Non-communicable diseases (NCDs) are currently a
burden for the global health system [1–3]. Previous
studies have indicated that sub-Saharan Africa has the
highest incidence rate of type 2 diabetes mellitus
(T2DM) which is projected to double from 12 million
to 24 million by 2030 [4, 5]. Low chronic inflammation
associated with T2DM has fueled investigations into
pro-inflammatory biomarkers as early indicators for
the detection of T2DM to curtail its progression and
associated morbidities [6–9]. However, there is a
knowledge gap on the effect of co-morbidities such as
hypertension and obesity, which are precursors for
low-grade chronic inflammation. Also, differences in
environmental settings could affect the levels of pro-
inflammatory markers among T2DM patients from an
African population.
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Previous studies conducted to assess variations in in-
flammatory markers associated with type 2 diabetes in
urban populations have indicated a significant difference
in the levels of interleukin 6 (IL-6) and tumour necrosis
factor α (TNF-α) [10, 11]. Nested case–control studies
conducted mainly among Caucasian, Asian and specific
native populations showed IL-6 and TNF-α as predictors
for T2DM with varied correlations with anthropometric
measurements [7, 8, 11]. High prevalence of obesity in
urban settings could cause an increase in pro-inflammatory
cytokines. IL-6 and TNF-α have been observed to have a
positive association with obesity in urban dwellers [12].
Most of these studies conducted on inflammatory markers
associated T2DM have predominantly sampled urban pop-
ulations [10, 13] without comparing the effect of lifestyle
and environmental differences on these marker levels in
rural settings of same geographical areas. As a result, little
is known about variations in pro-inflammatory markers be-
tween urban and rural dwellers with T2DM and compared
with healthy populations in both settings. Moreover, to
date, no study has been conducted on the dynamics of IL-6
and TNF-α among the T2DM Ghanaian population.
Hence, in this study, we assessed the variations in the
levels of, IL-6 and TNF-α in T2DM patients, associations
between anthropometric measurement and these pro-
inflammatory markers and the effect of co-morbidity with




A nested case–control study using data from a larger study;
Research on Obesity and Diabetes among African Migrants
(RODAM) [14]. The study data was collected between
2012 and 2014 in a population consisting of Ghanaians
aged 25 – 70 years. The urban population was recruited
from communities in the Kumasi Metropolis (the sec-
ond most densely populated city in Ghana) and Obuasi
Municipality, while the rural participants were from
villages in the same region (Ashanti). The procedure
for recruiting and interviewing of participants has been
published [14].
Sample size and study power
Sample size of 189 was estimated using the Cochran
method with an assumed T2DM prevalence of 14.4 % in
Ashanti region, Ghana at 95 % confidence level nested
into cases and controls for both rural and urban settings
assuming a default study power of 80 % with α of 5 %.
Selection criteria
A case was defined as participant diagnosed with fasting
plasma glucose of ≥ 7.0 mmol/L and plasma glucose
value of ≥ 11.1 mmol/L, 2 h after a 75 g oral glucose
tolerance test [15] with or without hypertension. A con-
trol for the study was a participant with fasting plasma
glucose ≤ 7.0 mmol/L without hypertension recruited in
the study sites. Participants were selected by simple ran-
dom selection.
Body weight was measured to the nearest 0.1 kg with a
digital scale (SECA 877, UK) after removal of footwear,
heavy clothing and pocket contents. Height to the near-
est 0.1 m was measured using a portable stadiometer
(SECA 217, UK). Body Mass Index (BMI) was computed
as weight in kg divided by the square of the height in
meters (kg/m2). Using appropriate cuff sizes, three blood
pressure readings were taken on the left arm with the
Microlife® WatchBP® (UK) in a seated position with at
least 15 min rest. The mean of the three readings was
used. Hypertension was defined as blood pressure of
140/90 mmHg or more [16]. Body fat% was estimated
using Bioimpedance and analysis with an impedance
analyzer (BODYSTAT® 1500 MDD, UK).
Written informed consent was obtained from each par-
ticipant for inclusion for the study while non-consenting
individuals and pregnant women were excluded from the
study. This study was approved by the Committee for
Human Research Publications and Ethics at the School of
Medical Sciences, Kwame Nkrumah University of Science
and Technology and the Komfo Anokye Teaching Hospital,
Kumasi.
Laboratory methods
Fasting venous blood samples were collected from each
participant by a phlebotomist at all study sites. Blood
samples collected were manually processed and ali-
quoted immediately according to standard operational
procedures and cryopreserved before transporting to la-
boratory for analysis as previously described [14]. Fasting
blood glucose was determined using the glucose de-
hydrogenase method with Accu-Chek® Perfoma Analyzer
(Roche, Germany) with a coefficient of variation of less
than 5 % compared to a laboratory chemistry analyzer.
Serum samples were analyzed for IL-6 and TNF-α using
highly sensitive sandwich ELISA. IL-6 was measured in
blood serum with a highly sensitive sandwich ELISA using
Human IL-6 ELISA test kit (BIOO SCIENTIFIC, USA)
with minimum detectable concentration of 8 pg/mL [17].
TNF-α levels were determined using sandwich ELISA
test kit with a minimum detection concentration of
12 pg/mL [18].
Statistical analysis
Data were entered into Microsoft Excel and statistical
analysis performed using Graphpad Prism 5 software.
Data normality was tested using D’Agostino and Pearson
omnibus normality test. The statistical difference be-
tween medians was estimated by the Mann–Whitney
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test. Associations were measured by coefficients of
Spearman’s partial correlation whiles controlling for age
and gender. Differences were considered statistically sig-
nificant at p < 0.05.
Results
Median levels of pro-inflammatory markers within rural
and urban settings
The median levels of TNF-α were 258.5 (32.4 – 514.5)
in urban T2DM and 188.0 (52.5 – 412.0) in rural T2DM
participants (Table 1). There were no differences in
TNF-α level between cases and controls within the same
setting (Table 1). In the urban population, the median
level of IL-6 was elevated among the control group [43.9
(0.9 – 716.2)] relative to the T2DM cases (p = 0.8327).
However, IL-6 levels among the rural population in
T2DM cases were significantly higher than in the con-
trols (p value < 0.0001).
Median levels of pro-inflammatory markers in T2DM cases
between rural and urban settings
IL-6 levels were significantly higher (p < 0.0001) among
the rural cases compared to those of the urban cases
(Fig. 1a). Inversely, urban cases had a significantly higher
(p = 0.0424) median level of TNF-α compared to rural
cases (Fig. 1b).
Measures of adiposity and fasting blood sugar between
rural and urban settings
Both urban and rural dwellers had median age of
50 years (Table 2) with ages ranging from 27 to 70 and
25–70 respectively (p = 0.8270). There were more female
participants in the urban (84 %) setting compared to
rural (56 %) area. Both BMI and body fat percentage
were significantly higher in the urban participants com-
pared with those in rural setting (p values of < 0.0001
and 0.0002 respectively).
Effect of co-morbidity of hypertension on levels of IL-6
and TNF-α
There was no association observed in IL-6 (p = 0.3571)
and TNF-α (p = 0.2581) levels in patients with only
T2DM compared with patients with T2DM+HTN
(Figs. 1c and 1d).
Associations between anthropometric and pro-
inflammatory markers in T2DM
IL-6 was negatively but weakly correlated with BMI
(r = −0.3765, p = 0.0258) in the urban study group
(Table 3).
Discussion
There are very limited studies conducted in Ghana to
assess the correlation of IL-6 and TNF-α among T2DM
patients with hypertension and non-diabetic participants
in rural and urban settings. Our results have showed
varying levels of IL-6 and TNF-α between T2DM cases
and controls in both rural and urban settings. The aver-
age level of IL-6 was higher in rural T2DM participants
compared with those in urban setting. However, higher
levels of TNF-α was observed among the study partici-
pants with T2DM in urban settings compared to those
of rural. In this study, we observed that co-morbidity of
hypertension had no significant effect on the levels of
IL-6 and TNF-α. To the best of our knowledge, this is
the first time a study of this kind has been conducted in
Ghana while only limited related studies have been con-
ducted in Africa [19]. The high level of IL-6 observed
among T2DM cases from the rural setting is fairly
Table 1 Characteristics of participants and laboratory
investigations
Variables Median (range)/n (%) p value
T2DM Cases Controls
Urban n = 37 n = 42
Age (years) 50 (27–69) 45.5 (31–70) 0.3477
Sex
Male 8 (22) 5 (12)
Female 29 (78) 37 (88)
Height (m) 1.6 (1.5 – 1.8) 1.6 (1.4 – 1.8) 0.0057a
Weight (kg) 66.4 (44.5 - 96.6) 62.5 (34.1 - 93.3) 0.1615
BMI (kg/m2) 27.3 (20.0 - 38.7) 26.4 (17.7 - 48.4) 0.1341
Body Fat (%) 48.3 (25.9 - 66.5) 48.0 (23.8 - 61.2) 0.9569
Hypertension 9 (23) NA
FBS (mmol/L) 7.5 (7.0 - 18.8) 5.7 (4.7 - 6.6) <0.0001a
IL-6 (pg/mL) 38.7 (12.3 - 129.3) 43.9 (8.0 - 500.0) 0.8327
TNF-α (pg/mL) 258.5 (32.4 - 514.5) 158.8 (14.18 - 6320) 0.0714
Rural n = 40 n = 70
Age (years) 51.5 (28–70) 49 (25–70) 0.3429
Sex
Male 19 (48) 29 (41)
Female 21 (52) 41 (59)
Height (m) 1.6 (1.5 – 1.2) 1.6 (1.2 – 1.8) 0.2796
Weight (kg) 59.70 (43.35 - 78.6) 58.1 (36.4 - 101.8) 0.7047
BMI (kg/m2) 21.57 (9.64 - 30.5) 20.68 (15.8 - 33.4) 0.5571
Body Fat (%) 42.9 (26.3 - 60.28) 43.1 (10.7 - 60.4) 0.8254
Hypertension 19 (51) NA
FBS (mmol/L) 7.5 (7.0 - 13.7) 6.0 (4.6 - 6.9) <0.0001a
IL-6 (pg/mL) 108.4 (26.0 - 478.0) 48.3 (4.8 - 432.8) <0.0001a
TNF- α (pg/mL) 188.0 (52.5 - 412.0) 184.5 (53.3 - 700) 0.5282
T2DM: type 2 diabetes mellitus, BMI: body mass index, FBS: fasting blood
sugar, IL-6: interleukin-6, TNF- α: tumour necrosis factor-alpha. NA:
not applicable
astatistically significant
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similar to what was found in previous studies con-
ducted by Krakoff and Nadeem [7, 10] although these
studies were conducted in a native Pima Indians in
Mexico and Pakistani populations respectively. How-
ever, in a related study by Al-Shukaili et al. (2013) [13]
among an urban Asian population, patients with T2DM
had decreased levels of IL-6 compared to healthy controls.
While a cross-sectional study by Hossain and colleagues
found no significant difference in serum levels of IL-6 be-
tween pre-diabetic participants and controls [20]. The dif-
ference between our findings and these other studies may
be attributed to several reasons, including differences in
case groups, varying sample sizes, gender composition, dif-
ferences in environmental and social settings and the dur-
ation of the T2DM disease. The significantly higher levels
of IL-6 among the rural T2DM compared to urban popula-
tion observed in our study, we suspect could result from
the synergistic effect of pro-inflammatory action of IL-6 in
T2DM and its anti-inflammatory myokine action [21] in-
duced by physical exercise. Circulating IL-6 has been found
to increase to about 100 fold in response to physical activity
and this is dependent on the intensity, duration and
Fig. 1 Variations in levels of pro-inflammatory markers and the effect of hypertension between settings. *p = 0.0424, ***p < 0.0001, ns = not
statistically significant, T2DM + HTN = type 2 diabetes mellitus + hypertension. a Overall levels of IL-6 among rural and urban participants.
b Overall levels of TNF-α among rural and urban participants. c Levels of IL-6 among rural and urban participants with only T2DM compared
with T2DM and Hypertension. d Levels of TNF-α among rural and urban participants with both T2DM and Hypertension
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endurance capacity [22–24] of the individuals. We suspect
that, the more physical and active lifestyle of rural dwellers
may likely predispose them to produce an increase levels of
IL-6 more than the relatively sedentary lifestyle among
urban dwellers. Lifestyle variations between rural and urban
dwellers could possibly have contributed to the marked dif-
ferences in the observed levels of IL-6.
In this study, T2DM urban cases had a significantly
higher average level of TNF-α compared to those of rural
cases. It has been established that, TNF-α, is predominantly
secreted from adipose tissues which are more among fe-
males [25]. In this study, majority of the study participants
with T2DM was females and many were of urban settings.
Females generally have more adipose tissues and body fat
percentage with a consequential increase in body weight
relative to their male counterparts. Hence, we suspect that
the high TNF-α levels may have been contributed by the
number of urban female participants with T2DM (Table 2).
Various pro-inflammatory factors are known to be associ-
ated and linked with the risk of T2DM and obesity, a meta-
bolic syndrome. However, differences in the socio-
demographic characteristics result in variations in obesity
among Ghanaian adults [26]. Consequently, this could ex-
plain for differences in the observed levels of TNF-α be-
tween the rural and urban populations. This assertion
agrees with findings by Park et al. (2005) which showed a
positive association of obesity and visceral adiposity with
high serum concentrations of C-reactive protein, IL-6 and
TNF-α [27]. Also, a similar study by Goyal et al. [12] found
that obese diabetics had higher levels of TNF-α compared
to non-obese diabetics [12].
There was no significant difference between the
mean values of IL-6 and TNF-α among participants
with T2DM and T2DM +HTN in both rural and urban
settings. However, median values of IL-6 and TNF-α in
T2DM + HTN group compared with T2DM group sug-
gests that co-morbidity with hypertension may possibly
have a cumulative effect. Previous studies have estab-
lished that lesions due to pulmonary arterial hyperten-
sion could cause activation of macrophages which
subsequently secretes several cytokines including IL-6
and TNF-α [28, 29]. However, this assertion could not
be advanced in our study since our sample size was
relatively small and could have contributed in the
values obtained.
We found in this study that BMI and TNF-α had a
positive but weak correlation for both rural and urban
settings, though not significant, but consistent with
findings from previous studies [12, 30] which found no
significant association. This positive linear relationship
could be attributed to an increase in the adipose mac-
rophages responsible for secreting TNF-α and the as-
sociated increase in adipose cells among persons with
high BMI. However, in this study, BMI had a significant
but negatively weak correlation with IL-6 in the urban
T2DM group contrary to earlier findings [30, 31], which
showed positive correlation implicating increase in adipos-
ity with a rise in the levels of adipokines. This difference in
our findings with these previous studies could be attributed
Table 2 Measures of adiposity and fasting blood sugar
between urban and rural settings
Variables Median (range)/n (%) p value
Urban Rural
n = 79 n = 110
Age 50 (27–70) 50 (25–70) 0.827
Age Category (years)
25-34 6 (7.59) 19 (17.27)
35-44 24 (30.38) 23 (20.91)
45-54 27 (34.18) 31 (28.18)
55-64 16 (20.35) 27 (24.55)
65+ 6 (7.59) 10 (9.09)
Sex
Male 13 (16) 48 (44)
Female 66 (84) 62 (56)
BMI 27.2 (17.7 - 48.4) 20.9 (15.0 - 33.4) <0.0001
BMI Category (kg/m2)
BMI < 18.5 4 (5.07) 20 (18.18)
18.5≤ BMI≤ 24.9 25 (31.65) 66 (60.00)
25.0≤ BMI≤ 29.9 27 (34.18) 18 (16.36)
BMI≥ 30 23 (29.11) 6 (5.45)
Body Fat% 48.1 (23.8 - 66.5) 43.1 (10.7 - 60.4) 0.0002
FBS 6.5 (4.7 - 18.8) 6.6 (4.6 - 13.7) 0.9400
FBS Category
FBS < 6.0 29 (36.71) 30 (27.27)
6.0≤ FBS≤ 6.9 13 (16.46) 40 (36.36)
FBS≥ 7.0 37 (46.84) 40 (36.36)
BMI = body mass index, FBS = fasting blood sugar
Table 3 Associations between anthropometric and
pro-inflammatory markers in T2DM
r (p value)
Setting IL-6 TNF- α
Rural
BMI 0.1094 (0.5131) 0.0698 (0.6773)
Body Fat % 0.0719 (0.6679) −0.0251 (0.8813)
Urban
BMI −0.3765 (0.0258) 0.1243 (0.4769)
Body Fat % 0.0467 (0.7901) 0.0374 (0.8312)
Adjusted for age and gender
BMI: body mass index, FBS: fasting blood sugar, IL-6: interleukin-6, TNF- α:
tumour necrosis factor-alpha, r: Spearman’s partial correlation coefficient
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to differences in the study group compositions, racial, en-
vironmental and nutritional differences.
There were some inherent limitations associated with this
study including our sample size. We had fewer males with
T2DM relative to the females especially in the urban setting
which may have influenced the results. Moreover, there are
confounders such as physical activity, infections and auto-
immune diseases that could influence the levels of these
pro-inflammatory biomarkers. The findings in this study
have shown that rural and urban settings could affect varia-
tions in IL-6 and TNF- α levels in T2DM population. Fur-
ther investigations into these and other pro-inflammatory
markers in specific populations is needed to ascertain their
relevance both as early predictors and diagnostic cut offs
for T2DM.
Conclusion
We conclude there was higher level of IL-6 among rural
type 2 diabetics compared to those in urban setting
whiles higher TNF-α level in urban than rural was found in
the Ashanti region of Ghana. There was no association be-
tween anthropometric measurement and IL-6 and TNF- α
levels and co-morbidity of T2DM with hypertension had
no effect on IL-6 and TNF- α levels.
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